Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEWLINE Trial: Intra-arterial Alteplase After Thrombectomy in Acute Ischemic Stroke
NCT07727395Phase 3Recruiting
- Sponsor
- People's Hospital 115
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by People's Hospital 115. Primary endpoints: Modified Rankin Scale score 0-1 at 90 days and Symptomatic Intracerebral Hemorrhage at 24 hours. Started Aug 2026; status: recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07727395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07727395.